BioSpace Movers & Shakers, Jan. 1
The Pharma Data
DECEMBER 31, 2020
Reimer replaces Charlotte Russel and will be responsible for Alligator’s drug development candidates, with an emphasis on bringing mitazalimab and ATOR-1017 into Phase II efficacy studies. Prior to that, Zhang was an equity research analyst at UBS in New York, where he covered the Major and Specialty Pharmaceutical Sector.
52 
Let's personalize your content